Remote Exposome Monitoring for Autoimmune Diseases
- Institution
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA
- Principal investigator
- Wilson Liao
- Funding
- $246K
- Duration
- 2023–2026
Moonbase score
Still being scored
Abstract
Project Summary The exposome, defined as the measure of all exposures for an individual and how those exposures relate to an individual's health, plays a key role in many autoimmune diseases. Measuring the exposome over time and understanding its effect on human health using sophisticated readouts such as -omics assays is a key priority for future clinical and translational studies. However, one of the major barriers to conducting such longitudinal exposome studies is their frequent reliance on in-person clinical research visits. In-person research visits, often requiring time-consuming travel to an academic medical center and absence from work, can significantly limit the geographic, racial, and socioeconomic representation of research participants. These in-person visits also typically occur every few months, limiting the temporal resolution of exposome data that can be measured. This proposal focuses on the implementation of innovative strategies for remote, home-based exposome monitoring and -omics measurements. Successful completion of this work will provide valuable resources for a future collaborative network studying the exposome.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of California, San FranciscoNot yet scored
Multi-racial genetic analysis of hidradenitis suppurativa
Wilson Liao · $666K · 2021–2026
- NIH · University of California, San FranciscoNot yet scored
UCSF Dermatology Training Grant
Wilson Liao · $288K · 1976–2029
- NIH · University of California, San Francisco66
Dendrite development, function, degeneration and regeneration
Yuh Nung Jan · $676K · 2024–2032